T Cell Leukemia (DBCOND0028440)

Identifiers

Synonyms

Leukemia, T Cell / T-cell Leukemia / Leukemia, T-Cell

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04090268	Precision Exercise in Children With Malignant Hemopathies	No drug interventions	treatment	Not Available	recruiting
NCT03553238	Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL	Cyclophosphamide Cytarabine Dexamethasone Doxorubicin Etoposide Idarubicin Mercaptopurine Methotrexate Pegaspargase Tucidinostat Vincristine	treatment	2 / 3	unknown_status
NCT04938115	Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia	No drug interventions	treatment	Not Available	completed
NCT03564704	Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL	Cyclophosphamide Cytarabine Dexamethasone Doxorubicin Etoposide Idarubicin Mercaptopurine Methotrexate Pegaspargase Tucidinostat Vincristine	treatment	2 / 3	unknown_status
NCT04264078	Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies	Cyclophosphamide Fludarabine Melphalan	treatment	0	unknown_status
NCT04973527	LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor	No drug interventions	treatment	1	terminated
NCT00611208	A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)	A-dmDT390-bisFv(UCHT1)	treatment	2	completed
NCT04411043	Observatory of Prolymphocytic Leukemia T	No drug interventions	Not Available	Not Available	recruiting
NCT03792256	Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)	Cytarabine Doxorubicin Hydrocortisone Methotrexate Palbociclib Pegaspargase Prednisolone Prednisone Vincristine	treatment	1	active_not_recruiting
NCT04840875	Phase I Clinical Trial of Autologous CD7-CAR T Cells in the Treatment of High-risk Acute T-cell Leukemia / Lymphoma	No drug interventions	treatment	1	recruiting
NCT03829540	CD4CAR for CD4+ Leukemia and Lymphoma	No drug interventions	treatment	1	recruiting
NCT06345027	Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)	No drug interventions	treatment	1	not_yet_recruiting
NCT00001249	Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac	Yttrium Y-90	treatment	1	completed
NCT00095381	Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia	Forodesine	treatment	2	completed
NCT00001533	Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine	Cyclosporine	treatment	1	completed
NCT05619861	CAR-T Cells in the Treatment of Malignant Hematological Tumors	No drug interventions	treatment	Not Available	recruiting
NCT02518750	Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma	Asparaginase Escherichia coli Bortezomib Bortezomib D-mannitol Clofarabine Cyclophosphamide Cytarabine Dexamethasone Etoposide Hydrocortisone Mercaptopurine Methotrexate Mitoxantrone Nelarabine Panobinostat Pegaspargase Vincristine	treatment	2	terminated
NCT00001941	Anti-Tac for Treatment of Leukemia	Daclizumab	treatment	1 / 2	completed
NCT06420076	Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells	No drug interventions	treatment	1 / 2	recruiting